Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension
Related Experiment Videos
Insights
Identifying renovascular hypertension (RVH) requires careful clinical assessment and advanced diagnostics. While new drugs and interventions manage blood pressure, preserving renal function and accurately assessing lesion significance remain key challenges.
Area of Science:
- Nephrology
- Cardiology
- Vascular Medicine
Background:
- Renovascular hypertension (RVH) diagnosis and management are evolving.
- Clinical clues are vital for identifying patients needing further evaluation for RVH.
- Accurate assessment of renal artery lesions' hemodynamic significance is crucial.
Purpose of the Study:
- To review current diagnostic and therapeutic strategies for renovascular hypertension.
- To highlight advancements in identifying and managing patients with RVH.
- To discuss the ongoing need for more sensitive diagnostic tests.
Main Methods:
- Review of diagnostic techniques including intravenous digital subtraction angiography and renal flow scans.
- Evaluation of antihypertensive drug classes like beta-blockers and ACE inhibitors.
- Assessment of surgical interventions and percutaneous transluminal renal angioplasty (PTRA).
Main Results:
- Newer diagnostic tools improve the identification of patients requiring renal arteriography.
- Antihypertensive drugs control blood pressure but do not guarantee renal function preservation.
- Improved surgical techniques have reduced mortality; PTRA offers a non-surgical option for selected patients.
Conclusions:
- Accurate interpretation of clinical findings remains essential for RVH diagnosis.
- Continued development of sensitive tests is needed to determine the significance of renal artery lesions.
- Multifaceted management including risk factor correction, medication, and interventions like PTRA is key for RVH patients.
Abstract:
Careful interpretation of clinical clues continues to provide valuable information to identify patients in whom further evaluation for renovascular hypertension (RVH) is needed. Newer diagnostic techniques such as intravenous digital subtraction angiography and computer-generated renal flow scans have helped to more accurately identify patients in whom renal arteriography is indicated. More sensitive and specific tests are still needed to establish the hemodynamic significance of renal artery lesions. New classes of antihypertensive drugs, particularly beta-blockers and angiotensin-converting enzyme inhibitors, have enabled the control of blood pressure in most patients with RVH but do not assure preservation of renal function. An aggressive search for and correction of coexisting risk factors, and improved surgical techniques, have resulted in lower surgical mortality. The development of percutaneous transluminal renal angioplasty has provided an invasive, nonsurgical method for managing RVH in selected patients.